Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Mirabegron launched in the U.K. for treatment of overactive bladder

Feb. 26, 2013

Purdue Pharma prepares new TRPV1 antagonists

Feb. 26, 2013

Relypsa enrolls first patient in pivotal phase III patiromer trial

Feb. 22, 2013

Encouraging immunogenicity results reported from phase III program for NX-1207

Feb. 20, 2013

Galenica provides update on regulatory processes for PA-21

Feb. 12, 2013

ALK5 and/or ALK4 inhibitors developed at SK Chemicals

Feb. 6, 2013

EC approves BindRen for hyperphosphatemia

Jan. 29, 2013

Zerenex meets primary and secondary endpoints in phase III trial

Jan. 29, 2013

First patient treated in GCS-100 phase I/II trial

Jan. 29, 2013

Cellmid anti-midkine antibodies show promising results in mouse model of diabetic nephropathy

Jan. 24, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...